1. B-Raf kinase inhibitors for cancer treatment;Li;Curr. Opin. Invest. Drugs,2007
2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002
3. BRAF and RAS mutations in human lung cancer and melanoma;Brose;Cancer Res.,2002
4. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma;Kimura;Cancer Res.,2003
5. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia;Yuen;Cancer Res.,2002